@LewisStanding1 This systematic review & network meta-analysis found no difference in change in FEV1, SGRQ, dyspnoea or rescue medication use across #LAMAs in #COPD https://t.co/yull3kTn5k #RespEd
RT @manabunoda: Comparative efficacy of long-acting muscarinic antagonist monotherapies in COPD: a systematic review and network… https://t…
Comparative efficacy of long-acting muscarinic antagonist monotherapies in COPD: a systematic review and network… https://t.co/ckmJI2L4NP
RT @atscommunity: Comparative efficacy of long-acting muscarinic antagonist monotherapies in #COPD: https://t.co/6ctlzaUYI3
RT @atscommunity: Comparative efficacy of long-acting muscarinic antagonist monotherapies in #COPD: https://t.co/6ctlzaUYI3
RT @atscommunity: Comparative efficacy of long-acting muscarinic antagonist monotherapies in #COPD: https://t.co/6ctlzaUYI3
RT @atscommunity: Comparative efficacy of long-acting muscarinic antagonist monotherapies in #COPD: https://t.co/6ctlzaUYI3
Interesante comparativa de LAMA https://t.co/xE6OjAYmhI
RT @atscommunity: Comparative efficacy of long-acting muscarinic antagonist monotherapies in #COPD: https://t.co/6ctlzaUYI3
RT @atscommunity: Comparative efficacy of long-acting muscarinic antagonist monotherapies in #COPD: https://t.co/6ctlzaUYI3
RT @atscommunity: Comparative efficacy of long-acting muscarinic antagonist monotherapies in #COPD: https://t.co/6ctlzaUYI3
Comparative efficacy of long-acting muscarinic antagonist monotherapies in #COPD: https://t.co/6ctlzaUYI3
RT @atscommunity: Comparative efficacy of long-acting muscarinic antagonist monotherapies in #COPD: https://t.co/3ECDqowYgX
RT @atscommunity: Comparative efficacy of long-acting muscarinic antagonist monotherapies in #COPD: https://t.co/3ECDqowYgX
RT @atscommunity: Comparative efficacy of long-acting muscarinic antagonist monotherapies in #COPD: https://t.co/3ECDqowYgX
RT @atscommunity: Comparative efficacy of long-acting muscarinic antagonist monotherapies in #COPD: https://t.co/3ECDqowYgX
Comparative efficacy of long-acting muscarinic antagonist monotherapie | COPD @DovePress https://t.co/MJWJipeSA4
RT @atscommunity: Comparative efficacy of long-acting muscarinic antagonist monotherapies in #COPD: https://t.co/3ECDqowYgX
Comparative efficacy of long-acting muscarinic antagonist monotherapies in #COPD: https://t.co/3ECDqowYgX
Long-acting muscarinic antagonist #monotherapies in #COPD: a #systematicreview and network meta-analysis #NMA https://t.co/iss7BRZHpE
Comparative efficacy of long-acting muscarinic antagonist monotherapie | COPD https://t.co/NQdvsiJXFQ
A network meta analysis of long acting anticholinergics in COPD https://t.co/YZBIQVUijR